These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30788936)

  • 41. Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions.
    Kang J; Cho YS; Kim SW; Park JJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Youn TJ; Chae IH; Choi DJ
    PLoS One; 2015; 10(10):e0140421. PubMed ID: 26465755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of miRNA-126 on in-stent restenosis in patients with coronary heart disease: A protocol for meta-analysis and bioinformatics analysis.
    Qiu X; Wang J; Shi Z; Ji X; Huang Y; Dai H
    Medicine (Baltimore); 2021 Jun; 100(22):e25887. PubMed ID: 34087832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
    Joo HJ; Jeong HS; Kook H; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):114. PubMed ID: 29890945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-146a and miR-146b predict increased restenosis and rapid angiographic stenotic progression risk in coronary heart disease patients who underwent percutaneous coronary intervention.
    Zhang H; Zhang Q; Liu Y; Xue T
    Ir J Med Sci; 2020 May; 189(2):467-474. PubMed ID: 31680203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
    Tanındı A; Ekici B; Töre HF
    Turk Kardiyol Dern Ars; 2015 Jul; 43(5):457-64. PubMed ID: 26148078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention.
    Guo J; Gao Y; Ahmed M; Dong P; Gao Y; Gong Z; Liu J; Mao Y; Yue Z; Zheng Q; Li J; Rong J; Zhou Y; An M; Gu L; Zhang J
    Front Pharmacol; 2022; 13():816059. PubMed ID: 35685647
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
    Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and classification of neointimal proliferation and in-stent restenosis in post-stenting patients at 1-year interval: findings from non-invasive coronary computed tomography angiography.
    Xu N; Zhang J; Li M; Pan J; Lu Z
    Eur J Radiol; 2014 Oct; 83(10):1816-21. PubMed ID: 25112673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of coronary artery in-stent patency using 64-slice computed tomography.
    Zhao J; Zheng LL; Yang Y
    Coron Artery Dis; 2011 Dec; 22(8):540-52. PubMed ID: 21959714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-stent restenosis-prone coronary plaque composition: A retrospective virtual histology-intravascular ultrasound study.
    Seo DJ; Kim YK; Seo YH; Song IG; Kim KH; Kwon TG; Park HW; Bae JH
    Cardiol J; 2018; 25(1):7-13. PubMed ID: 29064537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention.
    Wihanda D; Alwi I; Yamin M; Shatri H; Mudjaddid E
    Acta Med Indones; 2015 Jul; 47(3):209-15. PubMed ID: 26586386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry.
    Gondo K; Ike A; Ogawa M; Shirai K; Sugihara M; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Miura S; Yasunaga S; Saku K
    J Cardiol; 2017 Apr; 69(4):652-659. PubMed ID: 27492658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.